RANI
Rani Therapeutics Holdings Inc
NASDAQ: RANI · HEALTHCARE · BIOTECHNOLOGY
$0.94
+5.87% today
Updated 2026-05-01
Market cap
$108.42M
P/E ratio
—
P/S ratio
66.39x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Rani Therapeutics Holdings Inc (RANI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-584.00%
ROE
-182.00%
ROA
-50.30%
Debt/equity
-2.23x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $979000.00 | $-26.60M | 100.00% | -2,764.56% | -2,716.75% |
| 2020 | $462000.00 | $-16.70M | 100.00% | -3,580.95% | -3,615.37% |
| 2021 | $2.72M | $-8.33M | 100.00% | -1,899.12% | -306.62% |
| 2022 | $0.00 | $-30.59M | — | — | — |
| 2023 | $0.00 | $-33.97M | — | — | — |
| 2024 | $1.03M | $-30.02M | 100.00% | -5,186.19% | -2,920.04% |
| 2025 | $1.63M | $-29.67M | 44.89% | -2,345.99% | -1,817.09% |